Pro-drug activation gene therapy using Herpes Simplex virus thymidine kinase (HSV-tk) gene transduction in combination with ganciclovir (GCV) is under investigation as a potential cancer therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback